What we know (and don't know yet) about the new COVID-19 variant that emerged in South AfricaEven though some of the genetic changes in the new variant appear worrying, it's still unclear if the virus will pose a significant public health threat. FDA: Merck COVID pill effective, experts will review safetyThe Food and Drug Administration posted its analysis of the pill ahead of a public meeting next week where academic and other experts will weigh in on its safety and effectiveness. The agency isn't required to follow the group's advice. Is sotrovimab neutralizing antibody for early COVID-19 available in Canada? GSK continues to work with provinces and territories to make sotrovimab available to appropriate patients. Would 'surgery selfies' improve speed of diagnosis for surgical site infections? Patients in the new study used the a tool sent photographs of their surgical wounds three, seven and 15 days after surgery. Getting flu and zoster vaccines on same day lowers flu vaccine uptake the next year Common side effects of zoster vaccine may be mistakenly attributed to the influenza vaccine. Text messaging service for monitoring COVID-19 at home reduces mortality Study finds a 64% relative reduction in the risk for death, and one life saved for every 400 patients enrolled in the remote monitoring service. Research roundup: COVID ICU practice guidelines, tools for coping with patient deaths, history of respiratory disease Here are three research papers that caught our eye this week. Moderna makes submission to Health Canada for COVID-19 vax for kids from 6 to 11 Studies for Spikevax for kids even younger are ongoing. POP QUIZ: Influenza vaccine—egg or latex allergy Test your knowledge of these more common allergies and flu vaccine. Higher rates of mortality in myocardial infarction patients with COVID-19 Study finds patients with out-of-hospital or in-hospital STEMI have significantly higher rates of in-hospital mortality in the presence of COVID-19 First Previous 49 50 51 52 53 Next Last
